BC Cancer Bispecific Antibody Education for Nurses

Bispecific antibodies are a specialized group of Hazardous Drugs that can elicit dramatic host reactions such as cytokine release syndrome (CRS) and related immune effector cell-associated neurotoxicity syndrome (ICANS) requiring monitoring, prompt recognition, and an advanced level of intervention.

This learning module provides nursing education to safely administer bispecific antibodies.


1 hour
34349

Contact Info

BC Cancer Professional Practice Nursing

BCCancerPPNAdmin@phsa.ca

For technical issues, please submit a ticket through LearningHub Help Site.